Cargando…
Antiviral combinations for severe influenza
Observational data suggest that the treatment of influenza infection with neuraminidase inhibitors decreases progression to more severe illness, especially when treatment is started soon after symptom onset. However, even early treatment might fail to prevent complications in some patients, particul...
Autores principales: | Dunning, Jake, Baillie, J Kenneth, Cao, Bin, Hayden, Frederick G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164787/ https://www.ncbi.nlm.nih.gov/pubmed/25213733 http://dx.doi.org/10.1016/S1473-3099(14)70821-7 |
Ejemplares similares
-
Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects
por: Hayden, Frederick G.
Publicado: (2009) -
Advances in antivirals for non‐influenza respiratory virus infections
por: Hayden, Frederick G.
Publicado: (2013) -
Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention
por: Hayden, Frederick G.
Publicado: (2000) -
Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
por: Cao, Bin, et al.
Publicado: (2020) -
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2022)